Epigenetics

10 results.

March 27, 2024 Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they have a virus could hold new promise for…

May 11, 2023 Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

GRAND RAPIDS, Mich. (May 11, 2023) — Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may…

October 20, 2021 American Cancer Society grant to support Van Andel Institute research into anti-cancer medications

GRAND RAPIDS, Mich. (Oct. 20, 2021) — Van Andel Institute’s Scott Rothbart, Ph.D., has earned a four-year, $792,000 Research…

September 22, 2021 Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute

Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer The Coriell Institute for Medical Research and…

August 18, 2021 Van Andel Institute earns prestigious grant to train postdoctoral fellows in cancer epigenetics

GRAND RAPIDS, Mich. (Aug. 18, 2021) — The National Cancer Institute has awarded Van Andel Institute a five-year, $1.7 million grant to establish a…

November 20, 2020 After more than a decade, ChIP-seq may be quantitative after all

GRAND RAPIDS, Mich. (Nov. 20, 2020) — For more than a decade, scientists studying epigenetics have used a powerful method called ChIP-seq to map changes…

December 5, 2018 Teaming up to accelerate scientific discovery

How close collaboration between academic labs, the biotech sector and a highly competitive federal grant program bolsters biomedical research innovation and cutting-edge technology…

November 28, 2018 High-throughput platform enables scientists to map activity of an emerging class of cancer drug targets

GRAND RAPIDS, Mich. (Nov. 28, 2018) — A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for…